Federal officials are investigating the use of antipsychotic drugs in children enrolled in Medicaid. The Wall Street Journal reports the probe was sparked by concerns the drugs are being prescribed too often to treat behavior problems in very young children.
The chairman of the California Assembly Health Committee announced he will examine the issue of fraud in taxpayer-funded drug rehab clinics, during a hearing on the state’s Medicaid program. The problems in the clinics were uncovered through an investigation by CNN and The Center for Investigative Reporting.
The national association representing pharmacy benefits managers, which administer prescription drug plans for more than 210 million Americans, has released recommendations aimed at reducing prescription drug abuse and fraud in Medicare.
A New Jersey congressman announced this week he will introduce legislation aimed at reducing prescription drug abuse among Medicare participants. Frank Pallone, Jr., is proposing to increase the requirements for verifying the validity of prescriptions before Medicare pays for the drugs.
Many Medicaid programs make it difficult for people addicted to opioids to receive medications to treat their addiction, according to a new report. The American Society of Addiction Medicine says private insurance companies also are restricting access to these treatments.
Medicare paid for prescriptions for drugs, including controlled substances such as oxycodone, written by professionals including massage therapists, home health aides and veterinarians, who were not authorized to do so, ABC News reports.
Between 3 million and 5 million new patients could soon receive addiction treatment under the Affordable Care Act, according to the Associated Press. The change will have a major impact on treatment for drug and alcohol addiction.
A growing number of children enrolled in Medicaid are taking antipsychotic drugs for off-label uses, a new study finds. These drugs are prescribed for a purpose that has not yet been approved by the U.S. Food and Drug Administration.